FR16C0003I2 - Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles - Google Patents

Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles

Info

Publication number
FR16C0003I2
FR16C0003I2 FR16C0003C FR16C0003C FR16C0003I2 FR 16C0003 I2 FR16C0003 I2 FR 16C0003I2 FR 16C0003 C FR16C0003 C FR 16C0003C FR 16C0003 C FR16C0003 C FR 16C0003C FR 16C0003 I2 FR16C0003 I2 FR 16C0003I2
Authority
FR
France
Prior art keywords
phenylalkanoic
triglycerides
treatment
ethyl esters
acids useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR16C0003C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRUSILOW ENTPR LLC
Brusilow Enterprises LLC
Original Assignee
BRUSILOW ENTPR LLC
Brusilow Enterprises LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23519346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR16C0003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BRUSILOW ENTPR LLC, Brusilow Enterprises LLC filed Critical BRUSILOW ENTPR LLC
Publication of FR16C0003I1 publication Critical patent/FR16C0003I1/fr
Application granted granted Critical
Publication of FR16C0003I2 publication Critical patent/FR16C0003I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR16C0003C 1995-02-07 2016-02-03 Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles Active FR16C0003I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38493595A 1995-02-07 1995-02-07
PCT/US1996/000940 WO1996024571A1 (en) 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Publications (2)

Publication Number Publication Date
FR16C0003I1 FR16C0003I1 (is") 2016-03-25
FR16C0003I2 true FR16C0003I2 (fr) 2016-06-24

Family

ID=23519346

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0003C Active FR16C0003I2 (fr) 1995-02-07 2016-02-03 Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles

Country Status (9)

Country Link
US (3) US5968979A (is")
EP (1) EP0858441B1 (is")
AT (1) ATE201013T1 (is")
AU (1) AU4858796A (is")
CA (1) CA2212047C (is")
DE (1) DE69612755T2 (is")
ES (1) ES2157422T3 (is")
FR (1) FR16C0003I2 (is")
WO (1) WO1996024571A1 (is")

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642543B1 (en) 2000-09-26 2003-11-04 The Board Of Trustees Of The Leland Stanford Junior University Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20030195255A1 (en) * 2002-04-12 2003-10-16 Summar Marshall L. Method for treating hepatic encephalopathies
US20040229948A1 (en) * 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
AU2003243272A1 (en) 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1567142A4 (en) * 2002-11-20 2005-12-14 Errant Gene Therapeutics Llc TREATMENT OF PULMONARY CELLS WITH HISTONE DEACETYLASE INHIBITORS
US20090260743A1 (en) * 2003-11-21 2009-10-22 William David Mawby Tire manufacturing method for improving the uniformity of a tire
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors
PL3133396T3 (pl) 2008-04-29 2019-03-29 Horizon Therapeutics, Llc Sposób leczenia z zastosowaniem leków wychwytujących amoniak
PL2330892T3 (pl) * 2008-08-29 2017-05-31 Horizon Therapeutics, Llc Sposoby leczenia z zastosowaniem leków wychwytujących amoniak
EP2760479B1 (en) 2011-09-30 2017-05-03 Horizon Therapeutics, LLC Nitrogen scavenging drug for use in a method of treating a nitrogen retention disorder
LT2846791T (lt) 2012-04-20 2017-04-10 Horizon Therapeutics, Llc Hpn-100, skirtas naudoti azoto susilaikymo sutrikimų gydymui
LT2922576T (lt) 2012-11-21 2018-02-12 Horizon Therapeutics, Llc Azotą surišančių vaistų, skirtų kepenų encefalopatijos gydymui, skyrimo ir įvertinimo būdai
WO2015057747A1 (en) 2013-10-14 2015-04-23 Hyperion Therapeutics, Inc. Methods of treating urea cycle disorders
IN2013MU03442A (is") 2013-10-30 2015-07-17 Lupin Ltd
CA2929688C (en) 2013-11-14 2023-06-13 Ultragenyx Pharmaceutical Inc. Solid compositions of triglycerides and uses thereof
EP3137116B1 (en) 2014-04-30 2020-12-16 The Johns Hopkins University Dendrimer compositions and their use in treatment of diseases of the eye
WO2016025741A1 (en) 2014-08-13 2016-02-18 The Johns Hopkins University Selective dendrimer delivery to brain tumors
CA3003589C (en) 2015-10-29 2021-12-07 The Johns Hopkins University Dendrimer compositions and methods for treatment of peroxisomal disorders and leukodystrophies
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
US11612660B2 (en) 2019-12-04 2023-03-28 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Also Published As

Publication number Publication date
US6060510A (en) 2000-05-09
EP0858441B1 (en) 2001-05-09
EP0858441A1 (en) 1998-08-19
ES2157422T3 (es) 2001-08-16
AU4858796A (en) 1996-08-27
DE69612755T2 (de) 2001-08-23
CA2212047C (en) 2010-11-16
FR16C0003I1 (is") 2016-03-25
US5968979A (en) 1999-10-19
DE69612755D1 (de) 2001-06-13
US6083984A (en) 2000-07-04
CA2212047A1 (en) 1996-08-15
WO1996024571A1 (en) 1996-08-15
EP0858441A4 (is") 1998-08-19
ATE201013T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
FR16C0003I2 (fr) Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles
FR15C0089I2 (fr) Antagonistes de recombinaison de l'il-5 utiles dans le traitement des troubles induits par l'il-5
FR2566394B1 (fr) Procede pour la preparation d'esters des acides acrylique et methacrylique par trans-esterification
MA23806A1 (fr) Procedes enzymatiques d'enrichissement en acides gras polyinsatures
EP0736545A3 (en) Ester of dextrin and fatty acids and its use
EP0963219A4 (en) PROCESSING NITROSATIVE AND OXIDATIVE STRESS TO TREAT A DISEASE
EP0925046A4 (en) TOPICAL PREPARATIONS AND METHODS FOR TREATING HEMORRHOIDS
ITPD940043A0 (it) "esteri attivi di polisaccaridi carbossilici"
EP0888053A4 (en) METHOD FOR TREATING CANCER AND INFECTIOUS DISEASES AND COMPOSITIONS THAT CAN BE USED THEREFOR
FR2566393B1 (fr) Procede pour la preparation d'esters des acides acrylique et methacrylique par trans-esterification
EP0810860A4 (en) Method of use of radicicol for treatment of inflammation and endotoxemia
EP0485172A3 (en) Esters and amides of substituted indenyl acetic acids
FR2611729B1 (fr) Procede de preparation d'un organopolysiloxane a fonction acrylate et/ou methacrylate
FR2721938B1 (fr) Complexes de titane et de zirconium d'acides carboxyliques en tant qu'inhibiteurs de corrosion
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
IT8948475A0 (it) Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
FR2741355B1 (fr) Composition pour le traitement d'objets que l'on souhaite nettoyer et/ou desinfecter
DE69631152D1 (de) Verhinderug von biologischen verschmutzungen durch anwendung von estern aus polyglykolen und fettsäuren
PL320922A1 (en) Application of mhc-ii bonding and/or somulating molecules in prevention and/or treatment of diseases involving inflammatory processes
FR2725443B1 (fr) Preparation d'acides carboxyliques ou des esters correspondants par carbonylation en presence d'iridium
FR2722798B1 (fr) 1procede de production d'acides gras2plantes oleagineuses
NO974486D0 (no) Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse
FR2747128B1 (fr) Procede et dispositif pour la fabrication d'esters d'acides gras a partir de graines oleagineuses